Israel Englander Solid Biosciences Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.51 - $7.56 $189,852 - $2.81 Million	-372,259 Reduced 54.03%	316,742 $148,000
Q2 2022 Aug 15, 2022	BUY	$0.43 - $1.24 $291,130 - $839,538	677,047 Added 5663.77%	689,001 $424,000
Q1 2022 May 16, 2022	SELL	$0.74 - $1.79 $405,158 - $980,046	-547,512 Reduced 97.86%	11,954 $14,000
Q4 2021 Feb 14, 2022	BUY	$1.69 - $2.46 $916,015 - $1.33 Million	542,021 Added 3107.03%	559,466 $979,000
Q3 2021 Nov 15, 2021	SELL	$2.38 - $3.77 $296,605 - $469,832	-124,624 Reduced 87.72%	17,445 $42,000
Q2 2021 Aug 16, 2021	BUY	$3.49 - $5.51 $295,048 - $465,820	84,541 Added 146.96%	142,069 $520,000
Q1 2021 May 17, 2021	SELL	$5.37 - $10.72 $4.21 Million - $8.4 Million	-783,603 Reduced 93.16%	57,528 $318,000
Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $2.39 Million - $6.04 Million	775,625 Added 1184.05%	841,131 $6.38 Million
Q3 2020 Nov 16, 2020	BUY	$2.02 - $3.08 $132,322 - $201,758	65,506 New	65,506 $133,000
Q2 2020 Aug 14, 2020	SELL	$2.1 - $3.42 $500,217 - $814,640	-238,199 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$2.31 - $4.43 $2.06 Million - $3.96 Million	-893,125 Reduced 78.95%	238,199 $569,000
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $954,056 - $4.36 Million	338,318 Added 42.66%	1,131,324 $5.03 Million
Q3 2019 Nov 14, 2019	BUY	$4.33 - $11.64 $938,354 - $2.52 Million	216,710 Added 37.6%	793,006 $8.2 Million
Q2 2019 Aug 15, 2019	BUY	$4.6 - $10.13 $2.26 Million - $4.99 Million	492,143 Added 584.82%	576,296 $3.31 Million
Q2 2019 Aug 14, 2019	SELL	$4.6 - $10.13 $657,128 - $1.45 Million	-142,854 Reduced 62.93%	84,153 $5.33 Million
Q1 2019 May 14, 2019	BUY	$7.19 - $32.37 $1.63 Million - $7.35 Million	227,007 New	227,007 $2.09 Million
Q3 2018 Nov 14, 2018	SELL	$36.35 - $51.7 $886,176 - $1.26 Million	-24,379 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$7.33 - $43.15 $1.8 Million - $10.6 Million	-245,358 Reduced 90.96%	24,379 $869,000
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $1.94 Million - $8.95 Million	269,737 New	269,737 $2.02 Million

Others Institutions Holding SLDB

# of Institutions

Shares Held

Call Options Held

Put Options Held

View Full List

About Solid Biosciences Inc.

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $30.6M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

More about SLDB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account